You just read:

Statement by Acting FDA Commissioner Ned Sharpless, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on stem cell clinic permanent injunction and FDA's ongoing efforts to protect patients from risks of unapproved products

News provided by

U.S. Food and Drug Administration

Jun 25, 2019, 14:46 ET